Senate Clears Stem-Cell Funding As Veto Looms

Law360, New York (July 18, 2006, 12:00 AM EDT) -- As expected, the U.S. Senate voted Tuesday to expand embryonic stem cell research, despite the threat of a veto by President George W. Bush.

The bill, which has already been approved by the U.S. House of Representatives, was passed with bipartisan support.

With 63 votes in favor and 37 votes in opposition, the bill’s margin is too narrow to override a threatened veto by President Bush, who has yet to use his veto power during his five-and-a-half-year presidency.

The issue has divided Republicans, with many high-ranking...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.